HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Naomi Kiyota Selected Research
Naomi Kiyota Research Topics
Disease
53
Neoplasms (Cancer)
03/2024 - 06/2012
28
Squamous Cell Carcinoma of Head and Neck
03/2024 - 04/2009
19
Thyroid Neoplasms (Thyroid Cancer)
02/2024 - 02/2015
15
Head and Neck Neoplasms (Head and Neck Cancer)
01/2023 - 04/2009
10
Neoplasm Metastasis (Metastasis)
06/2022 - 02/2008
7
Exanthema (Rash)
10/2022 - 10/2017
7
Carcinoma (Carcinomatosis)
04/2022 - 11/2012
7
Breast Neoplasms (Breast Cancer)
03/2022 - 04/2013
7
Disease Progression
02/2021 - 02/2015
5
Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2023 - 01/2016
5
Fatigue
06/2022 - 06/2012
5
Stomatitis
01/2020 - 04/2009
5
Stomach Neoplasms (Stomach Cancer)
01/2014 - 08/2012
4
Anaplastic Thyroid Carcinoma
01/2022 - 01/2017
4
Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 01/2014
4
Pain (Aches)
01/2020 - 01/2014
4
Hypertension (High Blood Pressure)
09/2018 - 02/2015
3
Infections
10/2022 - 05/2016
3
Papillary Thyroid Cancer
12/2019 - 09/2018
3
Diarrhea
08/2019 - 02/2008
3
Lymphatic Metastasis
04/2019 - 12/2018
3
Tongue Neoplasms (Tongue Neoplasm)
04/2019 - 08/2017
3
Hypopharyngeal Neoplasms
01/2019 - 01/2017
3
Proteinuria
12/2018 - 12/2015
3
Mucositis
12/2018 - 12/2016
3
Nausea
10/2017 - 04/2009
2
Hypoparathyroidism
11/2023 - 12/2020
2
COVID-19
01/2023 - 04/2022
2
Esophageal Neoplasms (Esophageal Cancer)
10/2021 - 12/2016
2
Febrile Neutropenia
09/2021 - 02/2008
2
Sarcoma (Soft Tissue Sarcoma)
04/2021 - 01/2021
2
Colorectal Neoplasms (Colorectal Cancer)
02/2021 - 10/2013
2
Neutropenia
01/2021 - 02/2008
2
medullary Thyroid cancer
01/2020 - 03/2019
2
Deglutition Disorders (Dysphagia)
12/2019 - 01/2017
2
Cachexia
01/2019 - 01/2014
2
Oropharyngeal Neoplasms
01/2019 - 12/2018
2
Body Weight (Weight, Body)
11/2016 - 12/2015
2
Hypothyroidism
10/2013 - 06/2012
2
Leukopenia
04/2009 - 02/2008
1
Disease Susceptibility (Diathesis)
01/2023
1
Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2023
1
Hypophysitis
01/2023
Drug/Important Bio-Agent (IBA)
22
Cisplatin (Platino)
FDA Link
Generic
03/2024 - 04/2009
19
lenvatinib
IBA
01/2022 - 02/2015
12
Nivolumab
IBA
01/2023 - 11/2016
9
Fluorouracil (Carac)
FDA Link
Generic
10/2023 - 04/2009
9
Docetaxel (Taxotere)
FDA Link
10/2023 - 02/2008
8
Phosphotransferases (Kinase)
IBA
02/2021 - 08/2012
7
Vascular Endothelial Growth Factor Receptors (VEGF Receptors)
IBA
02/2024 - 06/2012
7
Platinum
IBA
01/2022 - 11/2016
5
Tyrosine Kinase Inhibitors
IBA
04/2022 - 01/2013
4
Cetuximab (Erbitux)
FDA Link
01/2023 - 11/2016
4
Sorafenib (BAY 43-9006)
FDA Link
12/2019 - 01/2014
4
Biomarkers (Surrogate Marker)
IBA
05/2018 - 06/2012
3
Immune Checkpoint Inhibitors
IBA
01/2023 - 09/2020
3
Antibodies
IBA
01/2023 - 09/2020
3
Messenger RNA (mRNA)
IBA
01/2023 - 01/2022
3
ErbB Receptors (EGF Receptor)
IBA
06/2022 - 04/2018
3
Proteins (Proteins, Gene)
FDA Link
04/2022 - 01/2018
3
Gemcitabine
FDA Link
01/2021 - 01/2016
3
Iodine
IBA
01/2021 - 09/2018
3
Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)
IBA
01/2021 - 02/2015
3
S-1 plus cisplatin
IBA
06/2015 - 07/2009
3
GSK 1363089
IBA
10/2013 - 08/2012
2
HLA Antigens (Human Leukocyte Antigens)
IBA
01/2023 - 01/2016
2
Carboplatin (JM8)
FDA Link
Generic
01/2023 - 08/2019
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
06/2022 - 08/2012
2
regorafenib
IBA
06/2022 - 02/2021
2
BNT162 Vaccine
IBA
04/2022 - 01/2022
2
COVID-19 Vaccines
IBA
04/2022 - 01/2022
2
Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)
IBA
01/2021 - 01/2018
2
Serum Albumin
IBA
01/2019 - 04/2018
2
Albumins
IBA
01/2019 - 04/2013
2
Phenobarbital (Luminal)
FDA Link
05/2018 - 07/2014
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
04/2018 - 01/2016
2
Trastuzumab (Herceptin)
FDA Link
01/2018 - 08/2012
2
Methotrexate (Mexate)
FDA Link
Generic
01/2017 - 11/2016
2
Creatinine
IBA
02/2016 - 03/2013
2
Inulin
FDA Link
02/2016 - 03/2013
2
5- ((2,6- dichlorobenzyl)sulfonyl)- 3- ((3,5- dimethyl- 4- ((2- (pyrrolidin- 1- ylmethyl)pyrrolidin- 1- yl)carbonyl)- 1H- pyrrol- 2- yl)methylene)- 1,3- dihydro- 2H- indol- 2- one
IBA
10/2013 - 01/2013
2
Thyroid Hormones
IBA
10/2013 - 06/2012
1
binimetinib
IBA
02/2024
1
Dihydrotachysterol (AT 10)
IBA
02/2024
1
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
02/2024
1
encorafenib
IBA
02/2024
Therapy/Procedure
25
Chemoradiotherapy
03/2024 - 07/2009
22
Drug Therapy (Chemotherapy)
01/2023 - 02/2008
21
Therapeutics
11/2022 - 06/2012
19
Radiotherapy
03/2024 - 02/2008
4
Induction Chemotherapy
02/2021 - 02/2008
4
Neck Dissection (Radical Neck Dissection)
04/2019 - 08/2017
2
Lymph Node Excision (Lymph Node Dissection)
11/2023 - 01/2019
2
Drug Tapering
01/2022 - 09/2018
2
Immunotherapy
10/2021 - 09/2020
2
Genomic Medicine
07/2021 - 02/2021
2
Aftercare (After-Treatment)
12/2020 - 04/2018
2
Glossectomy
04/2019 - 12/2018
1
Tracheostomy
11/2023
1
Thyroidectomy
11/2023